The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF
Journal article
Mogensen, Ulrik M., Kober, Lars, Kristensen, Søren L., Jhund, Pardeep, Gong, Jianjian, Lefkowitz, Martin P., Rizkala, Adel R., Rouleau, Jean L., Shi, Victor C., Sweberg, Karl, Zile, Michael R., Solomon, Scott D., Packer, Milton and McMurray, John J.V.. (2017). The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF. American Heart Journal. 188, pp. 35 - 41. https://doi.org/10.1016/j.ahj.2017.02.034
Authors | Mogensen, Ulrik M., Kober, Lars, Kristensen, Søren L., Jhund, Pardeep, Gong, Jianjian, Lefkowitz, Martin P., Rizkala, Adel R., Rouleau, Jean L., Shi, Victor C., Sweberg, Karl, Zile, Michael R., Solomon, Scott D., Packer, Milton and McMurray, John J.V. |
---|---|
Abstract | Angiotensin converting enzyme inhibitors ( ACE-I ), are beneficial both in heart failure with reduced ejection fraction ( HF-REF ) and after myocardial infarction ( MI ). We examined the effects of the angiotensin-receptor neprilysin inhibitor sacubitril/valsartan, compared with the ACE-I enalapril, on coronary outcomes in PARADIGM-HF. |
Year | 2017 |
Journal | American Heart Journal |
Journal citation | 188, pp. 35 - 41 |
Publisher | Mosby Inc. |
ISSN | 0002-8703 |
Digital Object Identifier (DOI) | https://doi.org/10.1016/j.ahj.2017.02.034 |
Scopus EID | 2-s2.0-85016075621 |
Page range | 35 - 41 |
Research Group | Mary MacKillop Institute for Health Research |
Publisher's version | File Access Level Controlled |
Place of publication | United States |
Permalink -
https://acuresearchbank.acu.edu.au/item/85395/the-effects-of-sacubitril-valsartan-on-coronary-outcomes-in-paradigm-hf
Restricted files
Publisher's version
(1 files)
134
total views0
total downloads0
views this month0
downloads this month